Great to know that there is no reasonable expectation of litigation in the future based on the details released from the FDA report, and that we can get on with the positive aspects of TRT. Thanks Malmanu for repeatedly bringing up the subject even though you are not a holder. This shows that your compassion for ACR holders goes above and beyond your own holdings and is much appreciated. Please now abate in the knowledge that it is mission accomplished, and we are aware of your concern. We will all sleep better knowing you are on our side.
Lairy.
Add to My Watchlist
What is My Watchlist?
